Proffitt & Goodson’s Sanofi SNY Stock Holding History

Proffitt & Goodson’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-338	Closed	-$16K	–	425
2025 Q3	$16K	Buy	+338	New	+$16.3K	﹤0.01%	215

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Proffitt & Goodson's SNY Position: Q4 2025 in Review

Proffitt & Goodson sold out of Sanofi (SNY) in Q4 2025, closing a stake of 338 shares — an estimated $16K sold.

Proffitt & Goodson first reported a position in SNY in Q3 2025 and held it in 1 quarter. The position peaked at $16K in Q3 2025. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Proffitt & Goodson reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Proffitt & Goodson sold 338 Sanofi shares in Q4 2025, an estimated $16K.
Proffitt & Goodson first reported a position in Sanofi in Q3 2025 and held it in 1 quarter.
Proffitt & Goodson's Sanofi position peaked at $16K in Q3 2025.
758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Proffitt & Goodson's 13F filing for Q4 2025, filed 27 Jan 2026.